Newsroom | 2422 results

SAN FRANCISCO--(BUSINESS WIRE)--Qventus, the leader in automated care operations, today announces that health systems using its Care Gap and Coding Automation Suite have captured $17.1M in additional annualized reimbursement with the Malnutrition Care Automation, with one client seeing $7.6M in annualized reimbursement in the first four months. The company also announced the latest automation that identifies patients at risk of developing pressure injuries and automatically orchestrates the app...

ROCHESTER, N.Y.--(BUSINESS WIRE)--Token, the biometric identity assurance company, has been named a Gold Award recipient in the Identity Access Management category of the 2026 Cybersecurity Excellence Awards. The honor underscores Token’s role as identity becomes the control point for enterprise security. Credential compromise remains the leading cause of enterprise breaches, and AI has made the problem structurally worse — phishing, deepfakes, and social engineering now operate at machine spee...

SAN FRANCISCO--(BUSINESS WIRE)--Incode Technologies, Inc., a global leader in AI-powered identity security and fraud prevention, today announced the broad availability of GovFaceMatch, a solution that confirms identity against state Department of Motor Vehicles (DMV) databases in real time. GovFaceMatch is the first in the identity verification market to offer biometric matching of a live selfie against official DMV records, helping organizations grow without sacrificing security. It represents...

ROCHESTER, N.Y.--(BUSINESS WIRE)--Token, the biometric identity assurance company, today announced the appointment of Keith Ramee as Head of Partnerships. A strategic partnerships and business development executive with more than 20 years of experience building high-impact technology ecosystems, Ramee joins Token from Yubico, where he served as Vice President of Global Partnerships and Alliances. He joins Token’s revenue organization, reporting to Chief Revenue Officer Katy Nelson, and will lead...

PALO ALTO, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today reported financial results for the quarter ended June 30, 2026. Second Quarter 2026 Financial Highlights For the three-month period ended June 30, 2026, as compared to the same period of 2025: Reported total revenue of $335.0 million, an increase of 44%, driven by: Oncology revenue of $219.1 million, an increase of 38%, and approximately 104,000 oncology tests, an increase of 63%...

سياتل--(BUSINESS WIRE)--أعلنت Parse Biosciences,، إحدى الشركات الرائدة في مجال توفير حلول تسلسل الخلايا الفردية القابلة للاستخدام والتطوير، والتابعة لشركة QIAGEN، اليوم عن انضمام Xpress Genomics إلى برنامج مزوّدي الخدمات المعتمدين (CSP)، لتصبح أول مزوّد خدمات في منطقة دول الشمال الأوروبي. ستتيح الشركة، التي يقع مقرها في ستوكهولم، للباحثين الاستفادة من محفظة Parse لتقنيات Evercode الخاصة بتسلسل الخلايا المفردة عبر خط خدمات التسلسل القائم لديها.انبثقت Xpress Genomics من معهد كارولينسكا في عام 202...

西雅图--(BUSINESS WIRE)--(美国商业资讯)-- Parse Biosciences 是可扩展且易于获取的单细胞测序领域领先提供商，也是 QIAGEN 旗下公司。该公司今日宣布，Xpress Genomics 已加入其认证服务提供商（Certified Service Provider，CSP）计划，成为北欧地区首家加入该计划的服务提供商。总部位于斯德哥尔摩的 Xpress Genomics 将通过其现有测序服务平台，为研究人员提供 Parse 的 Evercode 单细胞测序产品组合。 Xpress Genomics 于 2022 年脱胎于卡罗林斯卡学院（Karolinska Institutet），已为 NGS 项目建立了自动化内部工作流程。加入认证服务提供商（CSP）计划后，公司将 Evercode 纳入其服务产品组合，使客户能够直接使用 Parse 的分池单细胞技术。 “我们的客户期待快速、高质量的服务成果。”Xpress Genomics 首席执行官 Christoph Ziegenhain 表示，“通过加入认证服务提供商（CSP）计划提供 Evercode，...

SEATTLE--(BUSINESS WIRE)--Parse Biosciences, der führende Anbieter von skalierbarer und leicht zugänglicher Einzelzell-Sequenzierung und ein Unternehmen der QIAGEN-Gruppe, gab heute bekannt, dassXpress Genomics dem „Certified Service Provider“ (CSP)-Programm beigetreten ist, damit das erste Unternehmen in der nordischen Region. Das in Stockholm ansässige Unternehmen wird Forschern über seine bestehende Pipeline für Sequenzierungsdienstleistungen das Evercode-Portfolio von Parse anbieten. Das im...

西雅圖--(BUSINESS WIRE)--(美國商業資訊)-- 可擴充且易於使用的單細胞定序領導廠商、QIAGEN旗下公司Parse Biosciences今日宣布，Xpress Genomics已加入其認證服務供應商（CSP）計畫，成為北歐地區首家加入該計畫的企業。這家總部位於斯德哥爾摩的公司將透過其現有的定序服務流程，向研究人員提供Parse的Evercode單細胞定序產品組合。 Xpress Genomics成立於2022年，起源於卡羅林斯卡學院，已為次世代定序（NGS）專案建置了自動化內部工作流程。加入CSP計畫後，該公司將Evercode納入服務，讓客戶能夠直接使用Parse的分池單細胞技術。 「我們的客戶期望獲得快速且高品質的分析結果。」Xpress Genomics執行長Christoph Ziegenhain表示，「透過CSP計畫提供的Evercode技術，我們為客戶的單細胞專案增添了一項強有力的選擇，且該服務同樣秉承我們實驗室一貫的處理時效與品質標準。」 「Xpress Genomics加入我們的CSP計畫，意味著研究人員將能夠獲得由一家以速度和精準度著稱的實驗室所...

SEATTLE--(BUSINESS WIRE)--Parse Biosciences, le prestataire leader de services évolutifs et accessibles de séquençage unicellulaire et filiale de QIAGEN, a annoncé aujourd’hui que Xpress Genomics avait rejoint son programme Certified Service Provider (CSP), devenant ainsi la première entreprise de la région nordique à le faire. Basée à Stockholm, cette dernière sera désormais en mesure de proposer aux chercheurs son portefeuille de solutions de séquençage unicellulaire Evercode, via son pipelin...